Pathology Clinical Trials
Here are the 6 most popular medical studies for pathology
Procedure
Repetitive Transcranial Magnetic Stimulation for Attention Deficit Hyperactivity Disorder (ADHD)
This trial is testing whether a new treatment, repetitive transcranial magnetic stimulation (rTMS), can help improve symptoms by targeting the brain regions that are thought to be underlying these symptoms.
Popular filter options for pathology trials
Pathology Clinical Trials With No Placebo
View 34 pathology medical studies that do not have a placebo group.
FAPi PET/CT Imaging for Cancer
This trial is looking at a new way to image cancer using a tracer called 68Ga-FAPi-46. The tracer is taken up by some cancers, and can be seen with PET imaging. This may provide additional information about various cancers in the future.
Imaging Agent
FAPi PET/CT Imaging for Prostate Cancer
This trial is testing a new imaging technique to see if it can detect prostate cancer. The technique uses a tracer called 68Ga-FAPi-46 which is taken up by some cancer cells. If successful, this technique could provide additional information about various types of cancer in the future.
1 for Prostate Cancer
There is much interest in understanding the role that vitamin D3 (cholecalciferol) plays in various cancers, and in the prognosis of various cancers once they are discovered. The purpose of this study is to examine the effects of vitamin D on prostate cancer-associated lesions and on vitamin D metabolites in prostate tissue. We will give vitamin D3 to men when they are scheduled to have their prostate removed because of cancer. The men will take vitamin D at one of 3 doses for 4-6 weeks, until the surgery is performed. We will compare the prostate tissue taken from the men receiving the higher doses of vitamin D to tissue from men assigned to the lower doses. We expect to find that the prostate removed at surgery from men who received the high-dose vitamin D treatment will appear more normal, and less cancer like. In addition, we will measure vitamin D metabolites in the prostate to confirm that these did accumulate in the prostate to bring about the effects observed.
View More Pathology Trials
See another 12 medical studies focused on pathology.
Frequently Asked Questions
Introduction to pathology
What are the top hospitals conducting pathology research?
In the realm of pathology, hospitals dedicated to unraveling the mysteries of diseases and improving patient outcomes take center stage. Among them is The University of Alabama at Birmingham in Birmingham, where innovative research is currently underway with two active pathology trials. While they may not have a history of previous studies in this field, their commitment to advancing knowledge and understanding cannot be overlooked. Similarly, UCLA's Jonsson Comprehensive Cancer Center in Los Angeles has also prioritized pathology research with two ongoing clinical trials focused on this crucial area. It is worth noting that these institutions are making significant strides despite not having conducted any past pathology trials.
Another prominent hospital contributing to the field is Henry Ford Health in Royal Oak. Although they currently have one active trial exploring aspects of pathology, their dedication to pushing boundaries warrants recognition. Meanwhile, across the country at UCSF Memory and Aging Center in San Francisco, researchers are actively engaged in one groundbreaking pathology trial aimed at shedding light on complex diseases affecting memory and cognition.
Lastly but by no means least important,Beth Israel Deaconess Medical Center located amidst Boston's vibrant medical community has been tirelessly working towards better understanding through its single active trial dedicated entirely to studying various facets within Pathology domain.Though it lacks historical data for referring back yet it remains undeterred showcasing sheer devotion prevailing among experts committed towards enhancing healthcare standards
These esteemed hospitals display unwavering commitment when it comes to investigating pathological conditions that affect countless individuals worldwide. Their collective efforts underscore the importance of cutting-edge research as we strive towards new breakthroughs essential for improving diagnostic accuracy and treatment strategies for patients everywhere
Which are the best cities for pathology clinical trials?
When it comes to pathology clinical trials, a few cities stand out as leaders in research and development. Chicago, Illinois tops the list with 3 active trials focusing on diverse areas such as body weight walking, hip arthroscopy, and imaging techniques like [18F]NAV4694. Royal Oak, Michigan follows closely behind with 2 ongoing studies exploring treatment options and surgical interventions like PAO with hip arthroscopy. Lastly, Birmingham in Alabama offers 2 active trials investigating innovative PET scans like [11C]PiB and 18F-labeled DPA-714. These cities provide individuals interested in pathology clinical trials access to cutting-edge research that pushes the boundaries of diagnostic methods and treatments.
Which are the top treatments for pathology being explored in clinical trials?
In the realm of clinical trials, several top treatments are currently being explored for pathology. These include:
- Daratumumab: Engaged in six active trials and 134 all-time breast cancer trials since its introduction in 2012.
- Belantamab mafodotin: Under scrutiny with four ongoing trials and a total of 26 breast cancer trials to date, starting from 2018.
- Lenalidomide: Being investigated in three active breast cancer studies alongside an impressive history of 280 clinical trials since its inception in 2003.
These innovative treatments offer hope for advancing the field of pathology and improving outcomes for patients worldwide.
What are the most recent clinical trials for pathology?
Exciting advancements are being made in the field of pathology, as recent clinical trials offer new possibilities for diagnosis and treatment. One such trial explores a virtual group speech therapy intervention program, guided by a patient partner. By leveraging technology, patients can benefit from personalized therapy sessions that address their specific needs. Additionally, verdiperstat shows promise as a potential treatment option for pathology patients. This compound is currently undergoing Phase 1 testing to evaluate its safety and efficacy. The research also includes studies focused on Down syndrome-related pathology and the use of C-11 ER176 PET/CT imaging to aid in diagnosis. These groundbreaking trials signify significant progress in understanding and managing various pathologies, bringing hope to both patients and medical professionals alike.
What pathology clinical trials were recently completed?
Several recent clinical trials in the field of pathology have successfully concluded, signifying significant advancements in diagnosing and understanding diseases. Notably, a trial focusing on Uproleselan sponsored by Washington University School of Medicine was completed in October 2021. Additionally, the National Cancer Institute wrapped up a trial investigating mRNA-1273 therapy in September 2021. Another noteworthy completion occurred with AgenTus Therapeutics' agenT-797 study back in January 2021. These trials highlight the dedication and progress made by researchers seeking to improve pathological diagnosis and treatment options for patients.